a b s t r a c t RTP801, a stress-related protein, is activated by adverse environmental conditions and inhibits the activity of mammalian target of rapamycin (mTOR) in promoting oxidative stress-dependent cell death. RTP801 exists both in the mammalian retina and the lens of the eye. Here, we observed RTP801 immunoreactivity in some retinal ganglion cells. Intravitreal injection of cobalt chloride (CoCl 2 ) to mimick hypoxia influenced retinal GFAP (glial fibrillary acidic protein) and heme oxygenase-1 (HO-1) levels, but did not affect RTP801 immunoreactivity or mRNA content relative to GAPDH. However, RTP801 mRNA was elevated when compared with Brn3a mRNA, suggesting that RTP801 is activated in stressed Brn3a retinal ganglion cells. In cultures of RGC-5 cells, RTP801 immunoreactivity was located in the cytoplasm and partly present in the mitochondria. An insult of blue light or CoCl 2 increased RTP801 expression, which was accompanied by cell death. However, in cultures where RTP801 mRNA was down-regulated, the negative influence of blue light and CoCl 2 was blunted. Rapamycin nullified the CoCl 2 -induced up-regulation of RTP801 and attenuated cell death. Moreover, rapamycin was non-toxic to RGC-5 cells, even at a high concentration (10 M). The protective effect of rapamycin on RGC-5 cells caused by the inhibition of RTP801 suggests that rapamycin might attenuate retinal ganglion cell death in situ, as in glaucoma.
Introduction
Studies in the past have shown that RTP801 (also referred to as REDD1 and encoded by Ddit4) is a stress-related protein that can regulate mammalian target of rapamycin (mTOR) and as a consequence, serves as a regulator of cell metabolism, proliferation and cell survival (Katiyar et al., 2009; Sabatini, 2009, 2012; Yoshida et al., 2010) . RTP801 was initially identified as a gene induced by DNA damage, suppressing mTOR function via a mechanism dependent on tuberous sclerosis protein 2 (Arachchige Don et al., 2012; DeYoung et al., 2008; Molitoris et al., 2011) . Induced RTP801 has been reported to promote death of postmitotic neurons (Malagelada et al., 2008; Shoshani et al., 2002) , but protects cells from apoptosis associated with oxidative stress (Shoshani et al., 2002) . Such observations suggest that the interaction of RTP801 and mTOR is complex and likely to vary in different cell types and in defined conditions. It also provides an explanation as to why rapamycin (a target for mTOR) protects neurons from death in cellular and animal toxin models of Parkinson's disease (Malagelada et al., 2010) and when RTP801 is knocked down (Malagelada et al., 2006 ), but does not do so when mTOR is instead affected by the full catalytic inhibitor Torin1 (Pong and Zaleska, 2003) .
It is generally thought that mTOR blockade suppresses the activation of the protein kinase Akt, which is known to have a major role in maintaining neuronal survival (Dudek and Datta, 1997; Franke et al., 1997a; Franke et al., 1997b) . Malagelada et al. (2010) proposed that phosphorylation of Akt at Thr308 (mimicked by rapamycin) acts as a pro-survival stimulus, while phosphorylation of Akt at Ser473 (mimicked by Torin1) promotes cell death. Since Akt participates in the retinal ganglion death caused by NMDA and in animal models of glaucoma (Levkovitch-Verbin et al., 2007; Manabe and Lipton, 2003; Nakazawa et al., 2005) , it is possible that rapamycin, via its influence on Akt, can attenuate ganglion cell death in such circumstances.
The relevance of RTP801 in the pathogenesis of certain human ocular diseases has been suggested in studies utilising RTP801 knockout mice, subjecting them to hypoxia, as in retinopathy of prematurity (Brafman et al., 2004) . RTP801-deficient mice have a decreased level of neovascularization and retinal pathological changes are reduced compared to wild-type mice. This shows that the development of retinopathy in a mouse model of retinopathy of prematurity is significantly attenuated in the absence of RTP801 expression. Moreover, in situ hybridisation has shown that low RTP801 hybridisation signals exist in all retinal layers, but increase in the outer part of the inner retinal layer following hypoxia (Brafman et al., 2004) . This implies that RTP801 expression may be present in cellular and/or vascular components associated with the outer portion of the inner nuclear layer. Significantly, Dejneka et al. (2004) demonstrated that systemic rapamycin inhibited retinal and choroidal neovascularization in mice, which is consistent with the known negative effect of rapamycin on RTP801 expression.
In the present study, we observed that RTP801 immunoreactivity was particularly pronounced in the ganglion cells of rodent retinas. This implies that RTP801 may play a role in the development of certain optic neuropathies involving the death of retinal ganglion cells. We therefore decided to investigate whether RTP801 was involved in the maintenance of cells in culture as a prelude to future studies on retinal ganglion cells in situ. We used RGC-5 cells, which have some characteristics of retinal ganglion cells (Krishnamoorthy et al., 2001) , and determined how RTP801 and cell survival were affected by blue light or CoCl 2 , which were used to simulate hypoxia. These insults were chosen because we have hypothesised that the blue light component of visual light entering the eye and hypoxia/ischaemia participate in the pathogenesis of glaucoma (see Osborne, 2010) .
Materials and methods

Materials
A transformed cell line (RGC-5 cells) with some ganglion cell characteristics (Krishnamoorthy et al., 2001 ) was used in this study. Anti-RTP801 was purchased from ProScience, anti-GFAP from DakoCytomation, anti-actin from Millipore, anti-heme oxgenase-1 (HO-1) from Enzo Life Sciences, anti-Brn3a and anti-apoptosis inducing factor (AIF) from Santa Cruz Biotechnology (CA, USA), and anti-OXPHOS (Mito-Profile total antibody cocktail) was obtained from MitoSciences. The apoptosis assay (APOPercentage) used was purchased from Biocolor (Carrickfergus,UK). PureLink RNA purification kit was from Ambion, Life Technologies. Power SYBR Green PCR Master Mix and High Capacity RNA-to-cDNA Master Mix were from Applied Biosystems (California, USA). Lipofectamine RNAiMAX and OPTIMEM medium, foetal bovine serum, DAPI, Alexa Fluor 488, DHE, penicillin, and streptomycin were from Invitrogen (Paisley, UK). CCCP (carbonyl cyanide 3-chlorophenylhydrazone), as well as the other chemicals and reagents were generally from Sigma-Aldrich (St. Louis, MO, USA), unless indicated otherwise.
Treatment of cultures
RGC-5 cells were maintained in Dulbecco's modified Eagle's medium (D-MEM) supplemented with 10% foetal bovine serum, 25 mM glucose, 100 U/mL penicillin, and 100 g/mL streptomycin, and kept in a humidified atmosphere of 95% air and 5% CO 2 at 37 • C. Doubling time of these cells was approximately 24 h. Confluent cultures of RGC-5 cells from 75 cm 2 filter-capped cell culture flasks were generally passaged at a ratio of approximately 1:6 to give a cell density of approximately 4-5 × 10 4 cells/ml. One hundred microlitres of these cells were placed in individual CellPlusTM 96-well plates or alternatively in 6-well plates for protein (electrophoresis/Western blotting) and mRNA analyses.
For viability studies, cells were allowed to settle in the 96-well plates for 24 h, then pre-treated for 1 h with a defined substance (e.g., rapamycin) or vehicle, before exposure to insults of CoCl 2 or blue light (250 lux, 400 nm), generally for 24 h before analysis. The light insult was delivered by a collection of LEDs that were arranged so that they fitted directly over the wells of 6-well plates, and placed at specific distances above the cell cultures to produce the desired intensities. The light source produced no detectable change in temperature of the cell culture medium for a period of up to 96 h.
Analysis for cell death by fluorescein diacetate (FDA) and propidium iodide (PI)
Cell death was measured by incubating cells on coverslips with 5 M of FDA for 2 min and 3 M of PI for 30 min at room temperature. Cells were then washed once with phosphate buffered saline (PBS) and examined under fluorescence microscopy (Schramm et al., 1990) .
Localisation of ROS
The dye 2 ,7 -dihydroethidium (DHE) was used to localise reactive oxygen species (Carter et al., 1994) . This assay is based on the fact that non-fluorescent DHE can passively enter living cells, where it can be oxidised by the superoxide anion or hydrogen peroxide to generate ethidium bromide, which binds to DNA and, when excited, emits red fluorescence that is proportional to the intracellular superoxide anion level. Briefly, after different treatments, DHE (10 g/ml) was added to cultures and maintained in the dark for 30 min. Therafter, red fluorescent ROS was detected by epifluorescence microscopy.
Apoptosis assay
The APOPercentage assay used was based on the movement of phosphatidylserine and detection in cell membranes. Briefly, 5 l of APOPercentage Dye was added to 96-well plates and left for 30 min Fig. 1 . Localisation of RTP801 immunoreactivity in sections of mouse, rat and human retinas (middle images in each case). Control sections (left images in each case) and sections of retina processed to detect RTP801 immunoreactivity were also stained with DAPI (right images in each case) to show the localisation of the outer nuclear (ONL), inner nuclear (INL) and ganglion cell (GCL) layers. Most of the RTP801 immunoreactivity was located in the GCL, especially in the mouse and rat retinas. Some specific RTP801 immunoreactivity was also located in the INL and other retinal layers, particularly in the human retina. This can be clearly seen when comparing sections processed for both RTP801 and DAPI (images on the right in each case).
at 37 • C. After incubation, the medium was removed and the cells washed twice with PBS before viewing by light microscope.
Cell count
Cultures were fixed in 4% paraformaldehyde for 15 min and washed in PBS. DAPI was added to identify individual cells and photographed using an inverted Leica DMI6000B fluorescence microscope (Leica Microsystems). Images were taken using a magnification to allow for the number of cells in an area of 9 mm 2 to be determined. For each culture, seven replicate fields of cells were determined using the software ImageJ 1.46r.
RTP801 extraction quantification by real-time polymerase chain reaction (PCR)
Total RNA was isolated from RGC-5 cells and also rat and mouse eye tissues using a PureLink RNA purification kit, which included DNase treatment. Purity of RNA samples was checked by analysis of A260/A280 ratios and the RNA concentration was determined spectrophotometrically. First-strand cDNA was synthesised from 0.5 g of total RNA, using a High Capacity RNA-to-cDNA Master Mix following the manufacturer's instructions. The reverse transcription step was carried out using the following programme: 25 • C for 5 min, 42 • C for 30 min and 85 • C for 5 min. Primers for RTP801, HO-1 and GFAP were internally referenced to acidic ribosomal protein (ARP), GAPDH or Brn3a, and designed using PrimerBLAST and synthesised by Sigma Aldrich (see Table 1 ). Expression levels of mRNA were assessed by relative quantification ( Ct method) in a 7500 Real-Time PCR thermal cycler (Applied Biosystems), using the Power SYBR Green PCR Master Mix. Cycling parameters were 95 • C for 10 min to activate DNA polymerase, then 40 cycles of 95 • C for 15 s and 60 • C for 1 min, with a final recording step of 78 • C for 20 s to prevent any primer-dimer formation. Each reaction was run in triplicate and dissociation curves were constructed to ensure only a single product was amplified. Data were analysed with the SDS 1.4 software (Applied Biosystems).
RNA interference methodology or siRNA
The culture medium of RGC-5 cells (seeded at 5 × 10 4 cells/ml) was changed after 16 h with transfection medium. The transfection medium lacked serum and antibiotics and consisted of Lipofectamine RNAiMAX with 50 nM siRNA (dissolved in OPTI-MEM medium) or without siRNA (mock). After 4 h, the transfection medium was removed and replaced with culture medium lacking antibiotics. After an additional 6 h, the cells were used for various studies when the down-regulation of mRNA was approximately 70-80%. To apply siRNA, ON-TARGET plus SMART pool, mouse DDIT4 or RTP801 (Thermo Scientific Dharmacon), a pool of four different target sequences were used. Controls routinely were mock transfections rather than ON-TARGET plus Non-targeting pool transfections, as they gave similar results.
Immunocytochemistry
RGC-5 cell cultures and retinas were fixed with 4% paraformaldehyde for 15 min and 2 h respectively, and then washed in PBS. Retinas were cryopreserved in sucrose and 10-m frozen sections produced. Cultures of retinal sections were next permeabilised with PBS/0.1% Triton (PBST) followed by exposure to goat serum (10% in PBST) for 60 min. Sections and cultures were then incubated overnight with primary antibodies (4 • C), washed with PBS and exposed to appropriate secondary antibodies conjugated to Alexa Fluor 488 or Alexa Fluor 594 (1:300) for 2 h. In some instances, DAPI (0.2 g/ml) was added to a wash solution of PBS and mounted in Dako Flourescence mounting medium (Dako, Inc). Images showing the localisation of RTP-801, HO-1, GFAP and Brn3a immunoreactivity were obtained using a Leica DM6000B fluorescence microscope (Leica Microsystems). Fig. 3A shows RTP801 mRNA levels in the retina and lens of mice and rats and also RGC-5 cells, all relative to GAPDH. Results are mean values ± SEMs where n = 4. Fig. 3B shows Western blots, where equivalent amounts of extracts from rat and mouse tissues (retina and kidney) were fractionated and samples processed with RTP801 or actin antibodies. The RTP801 antibody recognised two species, 35 kDa and 28 kDa, in the kidneys, but only the 28-kDa form in the retinal samples. Fig. 4 . GFAP (A1 and A2), RTP801 (B1 and B2) and HO-1 (C1 and C2) immunoreactivities in rat retina injected with vehicle (A1, B1 and C1) or CoCl2 (100 M) (A2, B2 and C2). Relative to vehicle-injected eyes, GFAP and HO-1 immunoreactivities were clearly up-regulated in the retina, being located primarily in Müller cells and astrocytes (arrows). However, no significant alteration in the intensity or RTP801 immunoreactivity in the ganglion cells (arrow heads) was observed in the CoCl2-treated tissues.
Western blot analysis
A cocktail lysis buffer that contained phosphatase and protease inhibitors (Sigma, Aldrich) was used to extract proteins from RGC-5 cultures (approximately 1 ml per 50 volume flask of confluent cells) and ocular tissues (approximately 1 ml/10 mg of tissue). Extraction was carried out by homogenisation followed by freeze/thawing, homogenisation (for ocular tissues) and sonication. Protein content was then determined using a Bicinchoninic acid protein kit (Sigma-Aldrich). Defined amounts of protein extracts and sample buffer (2 M Tris/HCl, pH 6.8, containing 8% SDS, 40% glycerol, 8% mercaptoethanol, and 0.002% bromophenol blue) were then mixed together and immediately heated for 5 min at 95 • C.
Equal amounts of proteins were fractionated by electrophoresis using 10% polyacrylamide gels containing 0.1% SDS, as described by Laemmli (1970) . Proteins were transferred to nitrocellulose and blots incubated overnight at 4 • C with various primary antibodies.
Detection was then performed with appropriate biotinylated secondary antibodies. The final nitrocellulose blots were developed with a 0.016% (w/v) solution of 3-amino-9-ethylcarbazole (AEC) in 50 mM sodium acetate (pH 5.0) containing 0.05% (v/v) Tween-20 and 0.03% (v/v) H 2 O 2 . The colorimetric reaction was stopped with 0.05% sodium azide/PBST solution and the blot recorded using the image acquisition system, Fusion FX7.
Intravitreal injection of CoCl 2
Adult Wistar rats (200-250 g in weight, on average) were anaesthetised by intraperitoneal injection of a mixture of ketamine/xylacine. A few drops of oxybuprocaine were applied to act as a local anaesthetic. Five microlitres of 10 mM CoCl 2 (giving a vitreal concentration of approximately 100 M) or vehicle (DMSO) were then injected over 30 s periods into the vitreous humour using a Hamilton syringe. Two days after the intraocular injections, the animals were sacrificed, their eyes enucleated and placed in 4% paraformaldehyde for 2 h or their retinas dissected and preserved in appropriate conditions for analysis by Western blotting and qPCR. Frozen sections of fixed eyes were produced and subsequently processed for immunohistochemistry.
Statistical analysis
Data, unless stated otherwise, were analysed for significance using a t-test and one-way analysis of variance (ANOVA), followed by a Bonferroni multiple-comparison test. They are expressed as a mean percentage of the control value plus SEM. p < 0.05 was considered significant. Fig. 1 shows the localisation of RTP801 immunoreactivity in mouse, rat and human retinas. RTP801 immunoreactivity was particularly strong in cells located in the ganglion cell layer of mouse and rat retinas and, to a lesser extent, human retina. Some immunoreactivity was also noted in the inner nuclear layer of all retinas, with traces in the other retinal layers too. Double staining of rat retinal sections suggested that many of the cells expressing the ganglion cell marker Brn3a also contained RTP801 (Fig. 2) .
Results
RTP801 was therefore primarily located in ganglion cells in the rat retina. However, not all Brn3a-positive cells contained RTP801 and some cells in the ganglion cell layer expressed neither Brn3a nor RTP801. Fig. 3 shows real-time PCR and Western blot data, confirming the presence of RTP801 in both the retina and lens of rats and mice. RTP801 has been reported to occur as two variants with molecular weights of 35 and 28 kDa (Shoshani et al., 2002) . Western blot studies confirmed that this was the case in mouse and rat kidney, but in the retinal samples, only the 28-kDa species was prominent (Fig. 3B ). As shown in Fig. 3A , RTP801 (relative to GAPDH) was more concentrated in the retina of both rats and mice, compared with their lens. The influence of chemical hypoxia (intravitreal injection of CoCl 2 ) on rat retinal RTP801, GFAP and HO-1 expression is shown in Fig. 4 . Intravitreal injection of CoCl 2 increased GFAP and HO-1 expression, which was observed primarily in the Müller and astrocyte glial cells. This was confirmed by real-time PCR studies, where, relative to GAPDH, retinal GFAP (Fig. 5A ) and HO-1 (Fig. 5B ) mRNA levels were significantly elevated by CoCl 2 . By contrast, chemical hypoxia did not have a clear effect on the normal RTP801 immunoreactivity (Fig. 4) , supported by the finding that the relative RTP801/GAPDH mRNA levels were statistically unaffected (Fig. 5C ). However, when comparing RTP801 mRNA levels with that of Brn3a, a significant up-regulation of RTP801 occurred in CoCl 2 -treated retinas (Fig. 5D) . Thus, it appears that RTP801 is up-regulated in stressed Brn3a cells in the process of dying because of CoCl 2 treatment.
RTP801 immunoreactivity exhibited an uneven punctate cytoplasmic distribution in RGC-5 cells, particularly in cells stressed by blue light or CoCl 2 , suggesting a possible mitochondrial localisation. However, double "staining" of RGC-5 cells by comparing the localisation of RTP801 immunoreactivity, the mitochondrial protein AIF, and the mitochondrial marker OXPHOS showed that RTP801 only partly occurred in the mitochondria (Fig. 6 ). This appeared to be the case both in control and stress-induced cells where RTP-801 was up-regulated.
The up-regulation of RTP-801 in RGC-5 cells induced by blue light or CoCl 2 is shown in Figs. 7-10. Basal amount of RTP801 immunoreactivity in RGC-5 cells maintained in the dark was low (Figs. 7E and 8E) , which was also reflected by the Western blot analysis (Fig. 9 ) and mRNA expression assays (relative to GAPDH) (Fig. 10) . RTP801 immunoreactivity (Figs. 7A and 8A ), RTP801 protein (molecular weight 28 kDa) (Fig. 9 ) and RTP801 mRNA (Fig. 10) were all elevated in RGC-5 cells in varying amounts after an insult of blue light or CoCl 2 .
Up-regulation of RTP801 immunoreactivity in mock-transfected RGC-5 cells (Figs. 7A and 8A ) caused by blue light or CoCl 2 was accompanied by increased cell death (Figs. 7C and 8C ). This was significantly less in cultures where RTP801 mRNA was down-regulated by siRNA transfection (Figs. 7A, 7D, 8B and 8D) . Semi-quantitative analysis of the numbers of dead cells determined in dead/live assays (Figs. 7C, 7D , 8C and 8D and Fig. 11) clearly Fig. 10 . Relative expression of RTP801 to GAPDH mRNA in control and cells transfected with siRNA to down-regulate RTP801, following exposure to various conditions for a period of 24 h. Compared with the control cells maintained in the dark, blue light (465-470 nm, 600 lux), CCCP (10 M) and CoCl2 (500 M) all increased RTP801 levels relative to GAPDH, with the influence of blue light and CCCP being particularly impressive. Significantly, red light (625-635 nm, 1000 lux) did not cause an up-regulation of RTP801. Importantly, RTP801 mRNA level was not changed in siRNA-transfected cells by any of the insults and was decreased relative to the level of RTP801 in control cells kept in the dark. Results are mean values ± SEMs, where cells were siRNA transfected on four different occasions and analysed in duplicate. Significant differences (*p < 0.01, **p < 0.05) were determined by paired t-test analysis. The effectiveness of the siRNA transfection methodology to down-regulate RTP801 mRNA in RGC-5 cells is shown in Fig. 10 . Here, the effect of various insults (blue light, red light, the mitochondrial un-coupler CCCP and CoCl 2 ) on mock-transfected cultures was compared with siRNA-transfected RGC-5 cultures. Compared with untreated control cells, the mitochondrial uncoupler CCCP, blue light and CoCl 2 all significantly elevated RTP801 mRNA levels, which was not the case for siRNA-transfected cells. It is noteworthy that RTP801 mRNA levels were lower in the control siRNA-transfected cells in red light than mock-transfected cells in the dark.
Rapamycin is not toxic and has neuroprotective characteristics, even at concentrations lower than 10 M. Exposure of RGC-5 cells to rapamycin for 24 h did not induce apoptosis or ROS formation, when compared with the respective influence of staurosporine or 100 M CoCl 2 (Fig. 12) . Moreover, rapamycin, unlike CoCl 2 , did not cause fragmentation of cell nuclei, an indicator of cell death (Fig. 13) . However, rapamycin, in a concentration-dependent manner, attenuated the negative effect of CoCl 2 on the survival of RGC-5 cells in culture, as did epigallocatachin gallate (EGCG) over 24 h (Fig. 15) . Significantly, CoCl 2 also stimulated RTP801 expression in RGC-5 cells over the same time period, which was attenuated by both EGCG and rapamycin (Fig. 14) . EGCG has a number of characteristics that are associated with it being able to attenuate a variety of negative effects on RGC-5 cells (e.g., Ji et al., 2011) . Rapamycin   Fig. 12 . The upper panels show cultures exposed to CoCl2 or rapamycin for 24 h and stained for ROS using the dye DHE. Compared with control cultures, most cells in the cultures exposed to CoCl2 gave an intense red fluorescence for ROS (arrows), associated with their nuclei. By contrast, cells exposed to rapamycin showed very little expression of ROS. The lower panels show cultures stained for phosphatidylserine by the APOPercentage method for apoptosis. A number of cells in cultures exposed to staurosporine (1 M) stained positively for phosphatidylserine (arrows) and those attached to the substrate exhibited shrinkage. By contrast, cells exposed to rapamycin were very similar in appearance to control cultures, with the odd cell in both cultures staining for phosphatidylserine (arrows). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.) Fig. 13 . RGC-5 cultures were exposed to CoCl2 or rapamycin for 24 h and then viewed by phase contrast microscopy in the absence and presence of DAPI, which stains nuclei blue. Compared with control cultures and cultures exposed to rapamycin, CoCl2 caused a fragmentation of nuclei (arrows), which occurs during the death process.
Fig. 14.
The upper panels show RTP801 immunoreactivity in RGC-5 cultures exposed to rapamycin or CoCl2 either alone or in combination with EGCG and rapamycin for 24 h. The lower panels show the same cultures exposed to DAPI to reveal cell nuclei (blue). The level of RTP801 immunoreactivity in control cultures was low and increased significantly in response to CoCl2, resulting in approximately 35% of the cells dying (see Fig. 15 ). Significantly, EGCG and rapamycin both nullified the elevation in the RTP801 expression induced by CoCl2 and consequently, attenuated cell death (see Fig. 15 ). Baseline levels of RTP801 immunoreactivity were unaffected by rapamycin. did not stimulate RTP801 immunoreactivity (Fig. 14) and importantly, real-time PCR analysis showed that rapamycin caused a concentration-dependent down-regulation of RTP801 mRNA over 24 h (Fig. 16A) . However, rapamycin also increased mTOR mRNA levels (Fig. 16B) . This observation is difficult to explain in the context of rapamycin's known effect on mTOR (Bové et al., 2011) , but might reflect the known actions of rapamycin on protein synthesis (Rüegg et al., 2007) .
Discussion
The present study provides evidence for the occurrence of RTP801 protein and mRNA in the rodent retina. Moreover, RTP801 immunoreactivity occurs in different parts of the retina, with its localisation clearly evident in ganglion cells of the rat, mouse and, to a lesser extent, human retina. These observations are partly supported by the report of Brafman et al. (2004) , where in situ hybridisation of RTP801 mRNA showed signals located in all retinal layers, with hypoxia inducing an elevation in these signals in the outer portion of the inner retinal layer. Our immunohistochemical finding that RTP801 occurred strongly in retinal ganglion cells could be important as it suggests that targeting RTP801 might help to preserve ganglion cell function in optic neuropathies like glaucoma. RTP801 is known to be induced during oxidative stress, hypoxia, DNA damage and energy depletion (Ellisen et al., 2002; Shoshani et al., 2002; Sofer et al., 2005; Wang et al., 2003) , processes all likely to be associated with ganglion cell death in glaucoma (Calkins, 2012; Osborne, 2008 Osborne, , 2010 Osborne et al., 2006) . Significantly, a body of evidence shows that in neuronal degeneration models of Parkinson's disease, RTP801 is induced, while its downregulation reduces the rate of apoptosis (Malagelada et al., 2006 (Malagelada et al., , 2008 (Malagelada et al., , 2010 Marras and Lang, 2008) . However, the functional consequences of RTP801 induction can vary considerably in different situations. For instance, induced RTP801 can protect cells from apoptosis associated with oxidative stress (Shoshani et al., 2002) , but promotes death in post-mitotic neurons (Malagelada et al., 2008; Shoshani et al., 2002) . This is probably because RTP801 participates in a variety of functions such as neurogenesis, differentiation and migration, as described in cortical development (Malagelada et al., 2011) . Such information suggests that care needs to be taken when examining the functional role of RTP801 in mature neurones in situ as opposed to assessing cells in culture.
Intravitreal injection of CoCl 2 clearly caused retinal toxicity, as indicated by an up-regulation of HO-1 and GFAP, both in terms of mRNA (in relation to GAPDH) and immunoreactivity. However, there was no clear change in RTP801 immunoreactivity or mRNA levels (relative to GAPDH) in these cases. Despite this finding, we believe that CoCl 2 treatment does result in RTP801 mRNA being induced in stressed retinal ganglion cells, as this was elevated when compared with Brn3a mRNA.
It is known that RTP801 affects the activation of mTOR (mammalian target of rapamycin), an evolutionarily conserved kinase that affects a variety of cellular responses, including protein translation, energy use, proliferation, differentiation and survival (Bové et al., 2011; Corradetti et al., 2005; Jacinto and Lorberg, 2008; Schwarzer et al., 2005) . Moreover, it has been reported that rapamycin protects neurons from death in both cellular and animal toxin models of Parkinson's disease (Malagelada et al., 2010) , as well as when RTP801 is knocked down through phosphorylation of Akt at Thr308 (Malagelada et al., 2006) . Such information formed the basis of our studies, which aimed to determine whether rapamycin/RTP801 actions on mTOR protected RGC-5 cells in culture from an insult of CoCl 2 . We Fig. 16 . Expression of RTP801 and mTOR mRNA levels relative to GAPDH in RGC-5 cells following exposure to rapamycin for 24 h. Both 1 and 10 M rapamycin caused a significant decrease and increase in RTP801 and mTOR, respectively. Results are mean values ± SEM of four different cultures; significant differences (*p < 0.05, **p < 0.01, ***p < 0.001) were determined by Student's un-paired t-test.
recognise that such information might not necessarily translate to what occurs in situ or during ganglion cell death in glaucoma.
Low amounts of RTP801 immunoreactivity were observed in the cytoplasm of unstressed RGC-5 cells, where it was only partly associated with mitochondria (Fig. 6) , as deduced by comparison with the localisation of the mitochondrial proteins AIF and OXPHOS (del Olmo-Aguado et al., 2012; Osborne et al., 2008) . However, when RGC-5 cells were exposed to CoCl 2 or blue light, a significant increase in cytoplasmic RTP801 immunoreactivity was noted (see Figs. 7A and 8A) . The presence of RTP801 within the mitochondria links mitochondrial functions and reduced ROS production (Horak et al., 2010) . Significantly, we demonstrated that blue light or CoCl 2 induced RTP801 expression in RGC-5 cells and that this process was associated with cell death, which in turn was drastically decreased when RTP801 was down-regulated. Such data provide strong support for the idea that CoCl 2 or blue light-induced cell death of RGC-5 cells involves an initial up-regulation of RTP801.
Blue light has a negative effect on RGC-5 cell survival, but red light does not (del Olmo-Aguado et al., 2012; Osborne et al., 2008; Osborne, 2010) . Indeed, evidence exists to suggest that red light wavelengths from far red to near-infrared, i.e., between 600 and 1000 nm, can attenuate a variety of injuries to the retina (Albarracin et al., 2011; Albarracin and Valter, 2012; Begum et al., 2013) . The observation (Fig. 10 ) that RTP801 mRNA levels in mock-transfected cells were unaffected by red light, but significantly elevated by blue light provides further support for the "protective" effect of red light.
To deduce whether rapamycin counteracted the effects of blue light or CoCl 2 on RGC-5 cells, we initially examined how mTOR and/or RTP801 mRNAs were affected by rapamycin. Rapamycin suppressed RTP801 mRNA expression, which was consistent with the idea of it acting as a neuroprotectant. However, the finding that rapamycin increased mTOR mRNA level was inconsistent with the idea that rapamycin attenuates the activity of RTP801. It should be noted that rapamycin does not impair the kinase activity of mTOR per se, but disrupts the assembly of mTOR protein complexes (Bové et al., 2011) . Moreover, rapamycin has been described to have a variety of additional influences, which include inhibiting the translation of mRNAs encoding ribosomal proteins and elongation factors (Terada et al., 1994) , inhibiting 70 kDa S6 protein kinases (Chung et al., 1992) and stimulating BDNF expression (Schratt et al., 2004) . It is also possible that a feed-back mechanism exists between RTP801 production, mTOR suppression and Akt signalling. Rapamycin is also known to cause feedback activation of Akt signalling through IGF-IR-dependent mechanisms (Wan et al., 2007) .
Our results on RGC-5 cells are in general agreement with the reports from others (Dudel et al., 1997; Franke et al., 1997a; Franke et al., 1997b; Malagelada et al., 2010) , indicating that inhibition of RTP801 production through the activation of mTOR maintains neuronal survival. Even at a concentration of 10 M, rapamycin did not cause any signs of toxicity or proliferation of RGC-5 cells (data not shown). Based on these findings, we suggest that rapamycin may also have the potential to protect non-proliferating retinal ganglion cells. Interestingly, survival of retinal ganglion cells in situ is enhanced by the activation of Akt signalling (Levkovitch-Verbin et al., 2007; Manabe and Lipton, 2003; Nakazawa et al., 2005) , while phosphorylation of Akt at Thr308 (mimicked by rapamycin) has also been proposed to be a pro-survival stimulus (Malagelada et al., 2010) . One future aim is therefore to investigate whether NMDAinduced toxicity of rat retinal ganglion cells in situ can be blunted by rapamycin.
In conclusion, our study shows that RTP801 occurs in the rodent retina, specifically in ganglion cells. Studies on RGC-5 cell cultures demonstrated that an up-regulation of RTP801 was associated with cell death. By contrast, reduced expression of RTP801, induced either by siRNA transfection or by rapamycin, was associated with cell survival. We suggest that rapamycin with its non-toxic characteristics might be used to directly affect RTP801 levels in retinal ganglion cells in situ and in the process, protect them from the insults that might occur in glaucoma.
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